According to promising new figures, it is predicted that one in three patients will survive cancer by the year 2020. With improvements to patient care eagerly anticipated, it is crucial to put measures in place, to ensure that such predictions are made reality.
Bolton, UK (PRWEB UK) 19 December 2013
Since previous recordings made in 1992, new research signals a significant decrease in the death rates of several common types of cancer- including prostate, breast and bowel cancer (1).
Unfortunately, despite positive developments in some areas, lung cancer survival rates still remain an area of concern, with 76% of sufferers expected to die from the disease. With the number of deaths marginally decreasing since 1992, experts are placing emphasis on the need for earlier diagnosis, and more equality in the accessibility of specialist surgeries (1).
Speaking on the news, Ms Williams, from medical negligence solicitors, Asons, said:
“The key to recovery for the majority of cancers relies on early detection. Unfortunately, in the case of lung cancer patients, for whatever reason, this hasn’t been possible.
“I believe that many patients fail to recognise the symptoms of cancer, refraining from visiting their health care authorities, instead choosing to use over the counter drugs to relieve the symptoms; for example, Lung Cancer can be characterized by a persistent cough, a symptom which is easy to over-look.
“Alongside this, there may be some blame lying amongst GP’s, for much the same reason. The symptoms of many cancers can present as those of more common ailments. Where GP’s are under time constraints, they may misdiagnose lung cancer as less serious issues such as Bronchitis, ultimately leading to delayed treatment and a worsened prognosis.
“This type of cancer is notoriously hard to diagnose, as the symptoms aren’t particularly unique. It is crucial that the public develop a clear understanding of the early signs and symptoms of the disease, making them less likely to accept a misdiagnosis from their GP.”
The release of this data, follows a recent study of nine million cancer sufferers in 29 countries; resulting in the discovery that cancer patients in Britain have some of the worst survival rates across Europe (1).
The study, carried out by Eurocare, found that in nine out of ten of the most common cancers, Britain had some of the lowest 5 year survival rates (1).
Continuing, Ms Williams said:
“The level of care provided by our national health service is of an extremely high standard, and it is perceived to be one of the best worldwide. However, there seem to be shortcomings where cancer diagnosis and treatment are concerned, and these need to be addressed.”
An early diagnosis for cancer is crucial to the future health of a patient. Receiving a delayed diagnosis, despite presenting the symptoms of cancer, could be seen as medical negligence.
Anyone that has suffered as a result of this could be eligible for compensation, for the resulting damage caused. For more information, visit http://www.asons.co.uk or phone 01204 521 133 to speak to a medical negligence solicitor.
(1) The Telegraph, Cancer: two in three patients will survive by end of decade, 06/12/2013
About Asons Solicitors:
Asons Solicitors is a Bolton-based law practice that specialises in personal injury and industrial disease claims. Founded by brothers Imran Akram and Kamran Akram, Asons Solicitors has developed to become a young and dynamic law firm that delivers practical solutions to clients in times of difficulty. Their continued focus on their staff has seen them awarded with the Investors in People “Gold Award”; which is reflected in the professional and personable approach they take in working with clients. They strive to grow and to develop, and their supportiveness and attention to detail ensures that their clients use them time and again.
All views expressed in this article are those of the individual and do not necessarily represent the beliefs of the firm.
For further information contact:
For the original version on PRWeb visit: http://www.prweb.com/releases/2013/12/prweb11413765.htm